A previous study showed that CYP2E1 plays a critical role in NASH development by promoting oxidative/nitrosative stress, protein modifications, inflammation, and insulin resistance [66]. This evidence concerns the gene CYP2E1 and metabolic dysfunction-associated steatohepatitis.